| 2024-10-14 | Class updated from VUS3 to non disease-causing |
Variant NM_000492.4:c.2619+106T>A
| Name | NM_000492.4:c.2619+106T>A |
| Protein name | NP_000483.3:p.(=) |
| Genomic name (hg19) | chr7:g.117235218T>A UCSC |
| Genomic name (hg38) | chr7:g.117595164T>A UCSC |
| #Exon/intron | intron 15 |
| Class | non disease-causing |
| WT sequence | ACACATAAATATGTATATATACACA T GTATACATGTATAAGTATGCATATA |
| Mutant sequence | ACACATAAATATGTATATATACACA A GTATACATGTATAAGTATGCATATA |
![]() Not found | ![]() Not found | dbSNP rs4148713 |
![]() Not found | ![]() |
11 individuals carrying this variant are reported in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 22 |
|---|---|
| Asymptomatic compound heterozygote | 3 |
| CF | 3 |
| CFTR-RD | 14
|
| Pending (NBS) | 2 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| Other | 4698 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| Other | 5243 | heterozygote | VUS3- Undef |
| Other | 4625 | heterozygote | VUS3- Undef |
| CF | 5341 | heterozygote | VUS3- Undef CF-causing- Undef |
| CF | 6441 | heterozygote | CF-causing- Undef CF-causing- Undef |
| CF | 5067 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 5765 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
| CBAVD | 5766 | heterozygote | varying clinical consequence- Undef CFTR-RD-causing- Undef |
| CBAVD | 5945 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
| CBAVD | 4663 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
| CBAVD | 5068 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
| CBAVD | 5325 | homozygote | c.1210-34_1210-6TG[13]T[5] - Trans c.769G>T - p.(Glu257*) - Trans |
| Pending (NBS) | 4620 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
| Pending (NBS) | 4645 | heterozygote | CF-causing- Undef VUS3- Undef |
| Asymptomatic compound heterozygote | 6440 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
| Asymptomatic compound heterozygote | 4656 | heterozygote | VUS3- Undef VUS3- Undef |
| Asymptomatic compound heterozygote | 5164 | heterozygote | CF-causing- Undef |
| Pancreatitis | 5332 | heterozygote | |
| Pancreatitis | 5339 | heterozygote | varying clinical consequence- Undef CFTR-RD-causing- Undef |
| Pancreatitis | 5364 | heterozygote | VUS3- Undef |
| Pancreatitis | 5949 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
| Pancreatitis | 5154 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|